SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Sellas Life Sciences is trending as investors show heightened anticipation ahead of the upcoming AACR Annual Meeting, where new clinical data on experimental cancer therapies is expected to be presented. The community is actively debating the significance of ongoing Phase 3 clinical trial developments, while simultaneously bracing for volatility related to options expiration and the high level of short interest surrounding the stock.

Maulcoin

Maulcoin is trending as its community actively rallies to defend the project's organic growth and transparency against perceived market manipulation and copycat tokens. Supporters are heavily focused on coordinating buying challenges to build a stronger price floor and establish the coin as a legitimate, community-led project.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is currently trending due to intense volatility surrounding the company's transition from a single-product biotech to a vertically integrated oncology platform centered on its proprietary Anktiva and Leonardo systems. Investors are closely monitoring a pivotal near-term regulatory catalyst regarding the FDA sBLA acceptance for Anktiva's label expansion, while active community discourse remains focused on balancing the company's aggressive growth narrative against persistent regulatory friction and speculative short-selling activity.

AXT, Inc. engages in the design, development, manufacture and distribution of compound and single element semiconductor substrates. It also sells specialty material substrates and raw materials used to make substrates and other related products. The company was founded by Morris S. Young and Davis Zhang in 1986 and is headquartered in Fremont, CA.

AXT Inc

AXT Inc. is seeing intense volatility driven by speculation around its indium phosphide (InP) supply chain role in AI data centers, though the community is sharply divided between those betting on AI-driven supply bottlenecks and others calling the recent rally an unsustainable bubble fueled by aggressive institutional call buying and potential share dilution concerns. Discussions are heavily focused on the stock's massive run-up over the past year, with many investors debating whether current valuations are justified by market demand or if the symbol is vulnerable to a sharp correction as insiders trim their positions.

Bicycle Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development of a novel class of medicines, which the company refers to as bicycles, for diseases that are underserved by existing therapeutics. Its portfolio includes internal product candidates that are directed to oncology applications. The company was founded by Gregory Winter, John Tite, and Christian Heinis in 2009 and is headquartered in Cambridge, the United Kingdom.

Bicycle Therapeutics Plc - ADR

Bicycle Therapeutics is trending as investors focus on upcoming clinical data from the AACR conference, particularly concerning its lead asset BT5528 in combination studies. While community sentiment is divided between optimism regarding its strong cash runway and the potential of its radiopharma pivot versus concerns over past regulatory hurdles and pipeline restructuring, the stock remains a high-interest subject for those weighing binary biotech risk against a solid balance sheet.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas Semiconductor is trending as the community debates its position in AI infrastructure, with intense speculation surrounding its 800V-to-6V power delivery platforms and potential design wins with major hardware partners. Sentiment is sharply divided between bulls highlighting the company's energy-efficient GaN technology and long-term data center growth, and bears concerned about high valuation relative to current revenue and ongoing institutional short interest.

Litecoin is a decentralized, peer-to-peer digital currency designed to enable instant, near-zero cost payments to individuals and merchants worldwide. As an open-source global payment network that functions independently of central banks or intermediaries, its main value proposition lies in providing a scarce digital asset with a fixed maximum supply of 84 million tokens.  The network operates using a Proof of Work mechanism where computers solve complex puzzles to confirm transactions and secure the blockchain. It is distinguished by a block generation time of 2.5 minutes, which allows for faster transaction confirmations and a higher total throughput than earlier protocols. Key technical features include the Scrypt hashing algorithm, which promotes wider network participation, and MimbleWimble Extension Blocks, which improve user privacy by allowing transaction details to be hidden.  The LTC token is used for settling global payments, executing microtransactions through smaller units called litoshis, and diversifying digital portfolios with a highly liquid asset. New tokens are issued to miners as rewards for verifying blocks, though these rewards undergo a halving event approximately every four years to strictly control inflation. This process ensures the ledger maintains immutability, meaning records cannot be changed once they are saved to the global network.  Created by former Google engineer Charlie Lee, the project is supported by the Litecoin Foundation, a non-profit organization dedicated to ecosystem adoption. Unlike many venture-backed projects, it is maintained by a decentralized community of independent developers and a global network of miners. The project has seen recent institutional adoption, with entities like Lite Strategy and Luxxfolio Holdings adding significant amounts of LTC to their corporate treasuries as of late 2025.

Litecoin

Litecoin is generating significant community discourse as participants debate the impact of the LitVM testnet launch and the asset's historical performance relative to the broader crypto market. Investors are actively watching critical support and resistance levels while weighing long-term conviction in the project's utility against frustration over recent price consolidation and the lack of substantial institutional inflows.

Hertz Global Holdings, Inc. engages in the vehicle rental business through the Hertz, Dollar, and Thrifty brands. It operates under the Americas Rental Car (RAC) and International Rental Car (RAC) segments. The Americas RAC segment focuses on operations in the United States, Canada, Latin America, and the Caribbean. The International RAC segment includes the provision of rental and sales of vehicles and value-added services in other locations. The company was founded in 1918 and is headquartered in Estero, FL.

Hertz Global Holdings Inc. - Ordinary Shares (New)

Hertz Global Holdings Inc

Hertz is seeing heightened volatility and social media attention as traders monitor a potential short squeeze, fueled by high short interest and technical setups that resemble previous momentum plays in the rental car sector. The community is actively debating the stock's turnaround potential, with discussions focused on whether recent price action and institutional positioning indicate a structural reversal or merely speculative short-term volatility.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtion is gaining significant market attention as investors highlight its strategic partnerships with NVIDIA and its development of quantum sensing technology for defense and space applications. The community is actively discussing the stock's potential for a valuation re-rating, often comparing its current market cap to other quantum sector peers while noting its recent inclusion in high-profile quantum AI initiatives.

The 401jK (just kidding) meme is a satirical punch in the gut in the face of the concept of retirement and the popular US based 401(k) retirement plan and other pension plans around the world  Through the meme fueled humor, irony, satire &amp; inspiration from cypherpunk ideology, real life data, and current events... the 401jK community aims to comment on the fact that global markets are heavily manipulated for selfish purposes by the same people who control these pension funds... while also aiming to twist the heads of the 401k and global pension systems.  It is a retirement plan that seeks to make social, political, economic commentary fueled by the memes and dreams of the hive mind of the community that makes up 401jK  The rules have changed, and the game was always rigged.  It's time to wake up, adapt, rebel, and heal.  Welcome to 401jK

401jK

401jK is currently trending as a community-driven movement that mocks the traditional retirement system, with followers actively engaging in IRL raids and online campaigns to promote their anti-establishment narrative. While supporters highlight its unique long-term vision, active staking, and educational content, critics remain vocal about concerns regarding pump-and-dump risks and ongoing price volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Adaptive Biotechnologies Corporation $ADPT Shares Sold by Sumitomo Mitsui Trust Group Inc.

Sumitomo Mitsui Trust Group Inc. reduced its position in Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Free Report) by 46.6% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 1,947,963 shares of the company's stock after selling 1,702,683 shares during t...

Adaptive Biotechnologies Corporation $ADPT Shares Sold by Massachusetts Financial Services Co. MA

Massachusetts Financial Services Co. MA lessened its stake in Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Free Report) by 25.6% during the 4th quarter, according to its most recent 13F filing...

Insider Selling: Adaptive Biotechnologies (NASDAQ:ADPT) COO Sells 19,060 Shares of Stock

Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Get Free Report) COO Julie Rubinstein sold 19,060 shares of the stock in a transaction dated Thursday, April 16th. The stock was sold at an average...

Adaptive Biotechnologies (NASDAQ:ADPT) COO Sells $250,639.00 in Stock

Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Get Free Report) COO Julie Rubinstein sold 19,060 shares of the company's stock in a transaction on Monday, April 13th. The shares were sold at an...

Julie Rubinstein Sells 19,060 Shares of Adaptive Biotechnologies (NASDAQ:ADPT) Stock

Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Get Free Report) COO Julie Rubinstein sold 19,060 shares of the company's stock in a transaction that occurred on Friday, April 10th. The shares...

Adaptive Biotechnologies (NASDAQ:ADPT) Shares Up 8.2%  - Here's What Happened

Adaptive Biotechnologies (NASDAQ:ADPT) Trading Up 8.2% - Should You Buy...

Harlan Robins Sells 10,000 Shares of Adaptive Biotechnologies (NASDAQ:ADPT) Stock

Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Get Free Report) insider Harlan Robins sold 10,000 shares of the business's stock in a transaction that occurred on Wednesday, April 8th. The stock was sold at an average price of $14.85, for a total transaction of $148,500.00. Following the...

Adaptive Biotechnologies (NASDAQ:ADPT) Insider Sells $148,500.00 in Stock

Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Get Free Report) insider Harlan Robins sold 10,000 shares of Adaptive Biotechnologies stock in a transaction that occurred on Wednesday, April 8th...

Adaptive Biotechnologies (NASDAQ:ADPT) Insider Francis Lo Sells 22,564 Shares

Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Get Free Report) insider Francis Lo sold 22,564 shares of the firm's stock in a transaction on Wednesday, April 8th. The shares were sold at an...

Adaptive Biotechnologies (NASDAQ:ADPT) CEO Sells $1,200,814.12 in Stock

Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Get Free Report) CEO Chad Robins sold 83,332 shares of the firm's stock in a transaction that occurred on Monday, April 6th. The stock was sold at...

Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. The company was founded by Chad Robins, Harlan Robins, and Chris Carlson on September 8, 2009 and is headquartered in Seattle, WA.

ADPT
Adaptive Biotechnologies Corp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest ADPT News

ADPTAdaptive Biotechnologies Corp